THURSDAY, MAY 7th, 2020


Fort Worth Convention Center - 1201 Houston Street - Fort Worth, TX
ROOM 203 A/B

 
 

Registration and Breakfast Buffet: 6:15 AM - 6:30 AM
Presentations: 6:30 AM - 8:00 AM

 

6:15 AM

Registration / Breakfast

6:30 AM

Welcome and Introductions, Disclosure Information, Sponsor Acknowledgement, Pre-test

6:35 AM

Prophylaxis, Adherence, and Transitioning: Challenges in Young Adults
Joanna A. Davis, MD
Medical Director Comprehensive Pediatric Hemophilia Treatment Center
Associate Director, Pediatric Hematology/Oncology Fellowship Program
Associate Professor of Clinical Pediatrics
University of Miami Miller School of Medicine
Miami, FL
Tampa, FL

7:00 AM

Hemophilia in a Changing Treatment Landscape
Johnathan Roberts, MD
Associate Medical Director
Bleeding & Clotting Disorders Institute
Assistant Professor of Pediatrics
University of Illinois College of Medicine
Peoria, IL

7:25 AM

Optimizing Clinical Outcomes: Inhibitors, Clotting Factors, and Gene Therapy
Shannon Meeks, MD
Program Medical Director of Hemostasis/ Thrombosis
Aflac Cancer and Blood Disorders Center
Children's Healthcare of Atlanta
Associate Professor of Pediatrics
Emory University School of Medicine
Atlanta, GA

7:50 AM

Panel Discussion, Post-test

8:00 AM

Adjourn

ACCREDITATION

 

EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

EXCEL Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants + Nurse Practitioners: AAPA and AANP accept AMA Category 1 Credit from organizations accredited by the ACCME.

MOC CREDITS
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit."


EDUCATIONAL OBJECTIVES

 
 

Identify the management barriers and needs of young adults with hemophilia when transitioning to adult hemophilia treatment centers (HTCs)
   

Describe the current use and underuse of prophylactic factor VIII replacement therapy
   

Strategize to incorporate new extended half-life (EHL) products as part of an individualized approach to hemophilia A prophylaxis
   

Differentiate general hemophilia from hemophilia with inhibitors, including the unique challenges associated with inhibitors
   

Discuss new and emerging treatments in the ever-changing landscape of hemophilia
   
 

SUPPORTER

 

 

SANOFI GENZYME

 


REGISTRATION


EXCEL CE complies with the Americans Disabilities Act. If any participant is in need of reasonable assistance, please FAX a written request to 305-598-7252 for consideration at least 2 weeks prior to the activity.